Bone mineral density evaluation of XXXX with @entity6 .

@entity1 @entity1719 @entity6 @entity170 @entity1735 @entity79 @entity209 @entity3918 @entity4854
[Purpose] @entity6 is a @entity209 resulting from a defect in insulin secretion, insulin action, or both. A consequence of this is chronic @entity4854 with disturbances in @entity1735 , fat and protein metabolism. We investigated whether there is any difference among @entity3918 @entity1 and a control group in terms of lumbar and femur @entity79 ( @entity79 ), and standard deviation scores (Z score and T score). [Subjects and Methods] This randomized, prospective, controlled, single-blind study was conducted in the Physical Medicine and Rehabilitation Department Faculty of Medicine, Bezm-i Alem Vak  f University. @entity1 with @entity6 were included in the @entity1 groups. Healthy individuals were included in the control group. [Results] A total of 126 @entity1 completed the study (63 in the study group, 63 in the control group). There was no significant difference in the results of the laboratory examinations of the cases. The bone mineral densities of the cases were found to be significantly low in terms of the lumbar ( @entity1719 ) T scores in the type 2 @entity6 group. [Conclusion] Although @entity170 is one of the potential complications of type 1 @entity6 , its effect on @entity79 in type 2 @entity3918 is controversial. In different studies, the @entity79 values have increased, decreased or remained normal. With the exception of the lumbar ( @entity1719 ) T score, similar results were obtained in this study.
